$ACHC
Acadia Healthcare Company, Inc.

2018 Q1 Form 10-Q Financial Statement

#000119312518150794 Filed on May 03, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $742.2M $689.3M
YoY Change 7.67% 11.76%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $515.2M $466.5M
YoY Change 10.44% 10.41%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $39.80M $33.60M
YoY Change 18.45% 20.0%
% of Gross Profit
Operating Expenses $694.2M $630.7M
YoY Change 10.06% 7.94%
Operating Profit $145.7M $136.4M
YoY Change 6.87% 4.09%
Interest Expense -$45.20M -$42.80M
YoY Change 5.61% 14.75%
% of Operating Profit -31.02% -31.39%
Other Income/Expense, Net
YoY Change
Pretax Income $48.09M $48.48M
YoY Change -0.82% 49.28%
Income Tax -$2.786M $13.71M
% Of Pretax Income -5.79% 28.28%
Net Earnings $50.82M $34.96M
YoY Change 45.37% 36.09%
Net Earnings / Revenue 6.85% 5.07%
Basic Earnings Per Share $0.58 $0.40
Diluted Earnings Per Share $0.58 $0.40
COMMON SHARES
Basic Shares Outstanding 87.12M 86.76M shares
Diluted Shares Outstanding 87.29M 86.91M shares

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $57.80M $43.10M
YoY Change 34.11% 17.76%
Cash & Equivalents $57.81M $43.09M
Short-Term Investments
Other Short-Term Assets $120.9M $104.8M
YoY Change 15.36% 31.37%
Inventory $4.772M $4.723M
Prepaid Expenses $28.93M $28.42M
Receivables $325.1M $276.1M
Other Receivables $32.87M $45.77M
Total Short-Term Assets $503.9M $424.0M
YoY Change 18.84% 7.82%
LONG-TERM ASSETS
Property, Plant & Equipment $3.152B $2.750B
YoY Change 14.62% -17.62%
Goodwill $2.779B $2.684B
YoY Change 3.56% -3.16%
Intangibles $91.04M $83.72M
YoY Change 8.74% -18.4%
Long-Term Investments
YoY Change
Other Assets $55.17M $61.73M
YoY Change -10.62% 24.4%
Total Long-Term Assets $6.081B $5.642B
YoY Change 7.78% -10.49%
TOTAL ASSETS
Total Short-Term Assets $503.9M $424.0M
Total Long-Term Assets $6.081B $5.642B
Total Assets $6.585B $6.066B
YoY Change 8.56% -9.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $122.4M $92.67M
YoY Change 32.11% -21.6%
Accrued Expenses $167.2M $41.89M
YoY Change 299.17% -70.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $33.83M $34.81M
YoY Change -2.8% -49.72%
Total Short-Term Liabilities $389.6M $335.9M
YoY Change 16.01% -17.85%
LONG-TERM LIABILITIES
Long-Term Debt $3.208B $3.247B
YoY Change -1.19% -7.18%
Other Long-Term Liabilities $168.6M $166.0M
YoY Change 1.59% 33.34%
Total Long-Term Liabilities $3.377B $3.413B
YoY Change -1.05% -5.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $389.6M $335.9M
Total Long-Term Liabilities $3.377B $3.413B
Total Liabilities $3.858B $3.812B
YoY Change 1.21% -7.6%
SHAREHOLDERS EQUITY
Retained Earnings $479.4M $263.7M
YoY Change 81.8% 10.02%
Common Stock $2.524B $2.501B
YoY Change 0.92% 0.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.702B $2.236B
YoY Change
Total Liabilities & Shareholders Equity $6.585B $6.066B
YoY Change 8.56% -9.42%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income $50.82M $34.96M
YoY Change 45.37% 36.09%
Depreciation, Depletion And Amortization $39.80M $33.60M
YoY Change 18.45% 20.0%
Cash From Operating Activities $72.35M $57.01M
YoY Change 26.9% -2.81%
INVESTING ACTIVITIES
Capital Expenditures $70.33M $50.55M
YoY Change 39.13% -43.89%
Acquisitions
YoY Change
Other Investing Activities $4.066M $5.051M
YoY Change -19.5% 318.13%
Cash From Investing Activities -$78.69M -$58.10M
YoY Change 35.43% -91.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.734M -13.70M
YoY Change -65.45% -102.09%
NET CHANGE
Cash From Operating Activities 72.35M 57.01M
Cash From Investing Activities -78.69M -58.10M
Cash From Financing Activities -4.734M -13.70M
Net Change In Cash -11.07M 57.01M
YoY Change -119.42% -2.81%
FREE CASH FLOW
Cash From Operating Activities $72.35M $57.01M
Capital Expenditures $70.33M $50.55M
Free Cash Flow $2.023M $6.465M
YoY Change -68.71% -120.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
15200000
CY2018Q1 us-gaap Goodwill
Goodwill
2779401000
CY2018Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
24405000
CY2018Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
91036000
CY2018Q1 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
17588000
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
91036000
CY2014Q4 achc Consolidated Funded Debt Maximum
ConsolidatedFundedDebtMaximum
40000000
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
88235019 shares
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43087000
CY2018Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3666000
CY2018Q1 us-gaap Assets Current
AssetsCurrent
503893000
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
325148000
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
396836000
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2522745000
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
122430000
CY2018Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
22788000
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-301391000
CY2018Q1 us-gaap Assets
Assets
6584729000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57808000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87287865 shares
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87287865 shares
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
873000
CY2018Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
38956000
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
19300000
CY2018Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3698000
CY2018Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
76930000
CY2018Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
15160000
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
104908000
CY2018Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3247000
CY2018Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3247000
CY2018Q1 us-gaap Inventory Net
InventoryNet
4772000
CY2018Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94283000
CY2018Q1 us-gaap Interest Payable Current
InterestPayableCurrent
12257000
CY2018Q1 us-gaap Liabilities
Liabilities
3858452000
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6584729000
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
389641000
CY2018Q1 us-gaap Long Term Debt
LongTermDebt
3241918000
CY2018Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
33830000
CY2018Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3208088000
CY2018Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
40 State
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
128473000
CY2018Q1 us-gaap Other Assets Current
OtherAssetsCurrent
120937000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.42
CY2018Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10412000
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55172000
CY2018Q1 achc Tax Cuts And Jobs Act Of2017 Incomplete Accounting One Time Transition Tax Liability For Foreign Subsidiaries
TaxCutsAndJobsActOf2017IncompleteAccountingOneTimeTransitionTaxLiabilityForForeignSubsidiaries
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1000946 shares
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
168633000
CY2018Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2375000
CY2018Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
32867000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
28930000
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3151529000
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3548365000
CY2018Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
24658000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
479392000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8200000 shares
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2485000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3236556 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2730000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
538884 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
44.41
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1256902 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
45.17
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
2701619000
CY2018Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4439000
CY2018Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0
CY2018Q1 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
3247000
CY2018Q1 achc Accrued Expense Current
AccruedExpenseCurrent
35955000
CY2018Q1 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
48402000
CY2018Q1 achc Workers Compensation Deposits
WorkersCompensationDeposits
10000000
CY2018Q1 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
0
CY2018Q1 achc Net Cost Report Settlement Due From Due To
NetCostReportSettlementDueFromDueTo
11800000
CY2018Q1 achc Number Of Beds
NumberOfBeds
17800 Beds
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57063000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8166000
CY2017Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3945000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
471550000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
296925000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
347419000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2517545000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
102299000
CY2017Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
22788000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-374118000
CY2017Q4 us-gaap Assets
Assets
6424502000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67290000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87060114 shares
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87060114 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
871000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31342000
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3731000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
80333000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
99047000
CY2017Q4 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
12997000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3247000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3247000
CY2017Q4 us-gaap Goodwill
Goodwill
2751174000
CY2017Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
15056000
CY2017Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
87348000
CY2017Q4 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
17588000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
87348000
CY2017Q4 us-gaap Inventory Net
InventoryNet
4787000
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
90595000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
36370000
CY2017Q4 us-gaap Liabilities
Liabilities
3829214000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6424502000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
377389000
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
3239888000
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34830000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3205058000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
141213000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107335000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8488000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49572000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
166434000
CY2017Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2129000
CY2017Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
30455000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27320000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3048130000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3549000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3395549000
CY2017Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
22417000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
428573000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3802000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
405634 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
41.20
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
974566 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
47.89
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2572871000
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1012000
CY2017Q4 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
3247000
CY2017Q4 achc Accrued Expense Current
AccruedExpenseCurrent
37268000
CY2017Q4 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
50432000
CY2017Q4 achc Workers Compensation Deposits
WorkersCompensationDeposits
10000000
CY2017Q4 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
0
CY2017Q4 achc Net Cost Report Settlement Due From Due To
NetCostReportSettlementDueFromDueTo
9000000
CY2017Q4 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
22500000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M0D
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
198313 shares
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M15D
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
25.92
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020 pure
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y0M18D
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.39
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
42.25
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.33 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
54.71
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1636000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
259300 shares
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
87367 shares
CY2017 achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
0
CY2017 achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
205000
CY2017 achc Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y3M18D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1200000 shares
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2396000
CY2017Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4119000
CY2017Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-425000
CY2017Q1 us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
1900000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13976000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-185000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
56136000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
55951000
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
33613000
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2007000
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.283 pure
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
842000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2017Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3437000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-16993000
CY2017Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2142000
CY2017Q1 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
27709000
CY2017Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
689341000
CY2017Q1 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
10147000
CY2017Q1 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
679194000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48484000
CY2017Q1 us-gaap Profit Loss
ProfitLoss
34773000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12459000
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1710000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13711000
CY2017Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5886000
CY2017Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-42757000
CY2017Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
376421000
CY2017Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
18971000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-58095000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
57439000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
630710000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-13737000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57014000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
34958000
CY2017Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-185000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
136369000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21178000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-5868000
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
27046000
CY2017Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
-5600000
CY2017Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
83711000
CY2017Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3825000
CY2017Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
2495000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50549000
CY2017Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5051000
CY2017Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-865000
CY2017Q1 us-gaap Professional Fees
ProfessionalFees
43409000
CY2017Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
8638000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7396000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86908000 shares
CY2017Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
146000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86762000 shares
CY2017Q1 achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvision
1700000
CY2017Q1 achc Common Stock Withheld For Minimum Statutory Taxes Net
CommonStockWithheldForMinimumStatutoryTaxesNet
4234000
CY2017Q1 achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision As Percentage
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvisionAsPercentage
0.036 pure
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
313000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6919000
CY2018Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2525000
CY2018Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4768000
CY2018Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-287000
CY2018Q1 us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
2000000
CY2018Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
4293000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70327000
CY2018Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4066000
CY2018Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2704000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
50874000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9482000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
55000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
123546000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
123601000
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39773000
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1897000
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
92780000
CY2018Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
-7300000
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.058 pure
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1588000
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
Acadia Healthcare Company, Inc.
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001520697
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2018Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-940000
CY2018Q1 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
29364000
CY2018Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
742241000
CY2018Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
27465000
CY2018Q1 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
742241000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48088000
CY2018Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4802000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3368000
CY2018Q1 us-gaap Professional Fees
ProfessionalFees
54018000
CY2018Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
88231000
CY2018Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1043000
CY2018Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
509000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18793000
CY2018Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1268000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2786000
CY2018Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
13216000
CY2018Q1 us-gaap Indefinite Lived Intangible Assets Purchase Accounting Adjustments
IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
762000
CY2018Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-45243000
CY2018Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
411528000
CY2018Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20288000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-78686000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
72637000
CY2018Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-55000
CY2018Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
2186000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
694153000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-4734000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
72350000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
50819000
CY2018Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
55000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
145731000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
72727000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-20053000
CY2018Q1 us-gaap Reinsurance Retention Policy Excess Retention Amount Reinsured
ReinsuranceRetentionPolicyExcessRetentionAmountReinsured
75000000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6919000
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y1M6D
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
36475 shares
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
20.60
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022 pure
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M7D
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.66
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
37.46
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y4M24D
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.37 pure
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
51.41
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
97000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
323500 shares
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4689 shares
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
96000
CY2018Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
62500000
CY2018Q1 dei Trading Symbol
TradingSymbol
ACHC
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87294000 shares
CY2018Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
173000 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87121000 shares
CY2018Q1 achc Income Tax Reconciliation Foreign Dividends And Earnings Taxable
IncomeTaxReconciliationForeignDividendsAndEarningsTaxable
10900000
CY2018Q1 achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvision
1500000
CY2018Q1 achc Common Stock Withheld For Minimum Statutory Taxes
CommonStockWithheldForMinimumStatutoryTaxes
2126000
CY2018Q1 achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
0
CY2018Q1 achc Common Stock Withheld For Minimum Statutory Taxes Net
CommonStockWithheldForMinimumStatutoryTaxesNet
2030000
CY2018Q1 achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
112000
CY2018Q1 achc Number Of Facilities
NumberOfFacilities
584 Facilities
CY2018Q1 achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
CY2018Q1 achc Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P7Y10M9D
CY2018Q1 achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision As Percentage
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvisionAsPercentage
0.031 pure
CY2018Q1 achc Share Based Compensation Arrangement By Share Based Payment Award
ShareBasedCompensationArrangementByShareBasedPaymentAward
0.25 pure
CY2018Q1 achc Number Of Facilities Operated By Non Wholly Owned Subsidiaries
NumberOfFacilitiesOperatedByNonWhollyOwnedSubsidiaries
3 Facilities
CY2018Q1 achc Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit
19300000
CY2018Q1 achc Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense
TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
0
CY2018Q1 achc Transition Tax On Certain Repatriated Earnings Of Foreign Subsidiaries Payable Period
TransitionTaxOnCertainRepatriatedEarningsOfForeignSubsidiariesPayablePeriod
P8Y

Files In Submission

Name View Source Status
0001193125-18-150794-index-headers.html Edgar Link pending
0001193125-18-150794-index.html Edgar Link pending
0001193125-18-150794.txt Edgar Link pending
0001193125-18-150794-xbrl.zip Edgar Link pending
achc-20180331.xml Edgar Link completed
achc-20180331.xsd Edgar Link pending
achc-20180331_cal.xml Edgar Link unprocessable
achc-20180331_def.xml Edgar Link unprocessable
achc-20180331_lab.xml Edgar Link unprocessable
achc-20180331_pre.xml Edgar Link unprocessable
d537812d10q.htm Edgar Link pending
d537812dex103.htm Edgar Link pending
d537812dex104.htm Edgar Link pending
d537812dex311.htm Edgar Link pending
d537812dex312.htm Edgar Link pending
d537812dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending